SNCA and Parkinson disease: C57BL/6 mice received a unilateral stereotactic injection of recombinant AAV encoding human full-length alpha-synuclein (rAAV9-hSYN) (3.67×1013 viral genomes/ml) into the right SNpc to generate a mouse model of PD.